Other OTC - Delayed Quote • USD
Verisante Technology Inc. (VRSEF)
At close: April 4 at 10:51 AM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas A. Braun BA, J.D., L.L.B., LLM | President, CEO, Founder & Director | 78.79k | -- | 1968 |
| Ms. Emmeline Braun B.A. | CFO, Corporate Secretary & Director | 17.39k | -- | -- |
Verisante Technology Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.
Corporate Governance
Verisante Technology Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available